Wheatland Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$203K Buy
+2,325
New +$201K 0.84% 44
2020
Q1
Sell
-7,325
Closed -$694K 72
2019
Q4
$694K Sell
7,325
-4,300
-37% -$386K 0.88% 42
2019
Q3
$1.01M Sell
11,625
-2,050
-15% -$184K 0.92% 40
2019
Q2
$1.25M Sell
13,675
-1,921
-12% -$163K 0.94% 38
2019
Q1
$1.34M Hold
15,596
1.03% 33
2018
Q4
$1.2M Hold
15,596
1.05% 34
2018
Q3
$1.2M Hold
15,596
0.9% 37
2018
Q2
$1.06M Hold
15,596
0.85% 42
2018
Q1
$1.13M Sell
15,596
-112
-0.7% -$8.53K 0.93% 34
2017
Q4
$1.18M Hold
15,708
0.96% 36
2017
Q3
$1.21M Hold
15,708
1.03% 33
2017
Q2
$1.18M Sell
15,708
-781
-5% -$55.4K 1.06% 35
2017
Q1
$1.1M Sell
16,489
-1,116
-6% -$74.4K 0.98% 38
2016
Q4
$1.15M Sell
17,605
-112
-0.6% -$7.26K 1.02% 34
2016
Q3
$1.25M Hold
17,717
1.18% 31
2016
Q2
$1.31M Sell
17,717
-334
-2% -$23.1K 1.26% 29
2016
Q1
$1.17M Hold
18,051
1.2% 32
2015
Q4
$1.39M Hold
18,051
1.42% 26
2015
Q3
$1.49M Hold
18,051
1.61% 25
2015
Q2
$1.59M Sell
18,051
-112
-0.6% -$10.3K 1.53% 25
2015
Q1
$1.6M Sell
18,163
-223
-1% -$19.8K 1.6% 25
2014
Q4
$1.53M Hold
18,386
1.49% 25
2014
Q3
$1.55M Hold
18,386
1.55% 26
2014
Q2
$1.49M Sell
18,386
-1,395
-7% -$110K 1.36% 30
2014
Q1
$1.51M Buy
19,781
+335
+2% +$24.4K 1.54% 26
2013
Q4
$1.4M Buy
+19,446
New +$1.35M 1.47% 25

Other funds holding NVS

Wheatland Advisors's NVS Position: Q2 2020 in Review

Wheatland Advisors opened a new position in Novartis (NVS) in Q2 2020: 2,325 shares worth $203K. The stake represents 0.84% of the portfolio and ranks #44 among its holdings. This is a return to the name: Wheatland Advisors previously reported a position in NVS as recently as Q4 2019.

Wheatland Advisors first reported a position in NVS in Q4 2013 and has held it in 26 quarters since. The position peaked at $1.6M in Q1 2015. 1,128 funds tracked by Wall St. Rank hold NVS as of Q2 2020.

  • Wheatland Advisors held 2,325 shares of Novartis worth $203K as of Q2 2020.
  • Novartis was a new Wheatland Advisors position in Q2 2020.
  • Novartis made up 0.84% of Wheatland Advisors's portfolio in Q2 2020, its #44 holding.
  • Wheatland Advisors first reported a position in Novartis in Q4 2013 and has held it in 26 quarters since.
  • Wheatland Advisors's Novartis position peaked at $1.6M in Q1 2015.
  • 1,128 funds tracked by Wall St. Rank held Novartis as of Q2 2020.

Based on Wheatland Advisors's 13F filing for Q2 2020, filed 28 Jul 2020.